Impact of heliotherapy and phototherapy on the course of atopic dermatitis
DOI:
https://doi.org/10.12775/JEHS.2024.51.008Keywords
phototherapy, heliotherapy, atopic dermatitisAbstract
Introduction and purpose. Atopic dermatitis (AD) is a common chronic inflammatory skin disease that affects many children and adults around the world. It has been also empirically known that some environmental factors such as exposure to the sun can be beneficial for patients with AD. The purpose of this literature review is to present positive impact, as well as challenges and risks of heliotherapy and phototherapy on patients suffering from AD.
Material and methods. The article is a review of publications obtained from the PubMed database and published between 2017-2023. Based on the keywords "phototherapy" "heliotherapy"and "atopic dermatitis", 14 articles were selected. Finally, 1 meta-analysis and 3 observational studies were included in the rewiev.
Brief description of the state of knowledge. People with AD have a compromised skin barrier, which favors infiltration by activated Th2 cells, and their cytokine, causing thickening of the skin. It makes management of AD challenging. It is known that most patients’ skin condition improves due to sun exposure. This is why an artificial UV radiation (UVR) is employed for the treatment. The idea is to administrate a non-ionizing radiation to the skin. Both sunlight and artificial light have a significant immunosuppressive effect on the skin.
Summary. Phototherapy as well as heliotherapy improved skin condition of people suffering from AD. It was appreciable by the end of few weeks of studies and also afer 3 months, reflected by improvement in PO-SCORAD, VAS and DLQI scales. During some of the studies there have been incidents of side-effects. More research is necessary to define a long-term effect of this kind of treatment and the role of chronic and prolonged therapy of AD.
References
Frazier W, Bhardwaj N Atopic Dermatitis: Diagnosis and Treatment Am Fam Physician 2020 May 15;101(10):590-598. PMID: 32412211.
Langan SM, Irvine AD, Weidinger S Atopic dermatitis. Lancet 2020 Aug 1;396(10247):345-360 https://doi.org/10.1016/S0140-6736(20)31286-1 Erratum in: Lancet 2020 Sep 12;396(10253):758 PMID: 32738956
Napolitano M, Monfrecola G, Fabbrocini G, Fattore D, Patrì A, Patruno C Impact of sun exposure on adult patients affected by atopic dermatitis Ital J Dermatol Venerol 2021 Oct;156(5):558-561 https://doi.org/10.23736/S2784-8671.20.06582-7 Epub 2020 Sep 17 PMID: 32938161.
Rathod DG, Muneer H, Masood S Phototherapy 2023 Feb 16 In: StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 33085287
Kemény L, Varga E, Novak Z Advances in phototherapy for psoriasis and atopic dermatitis Expert Rev Clin Immunol. 2019 Nov;15(11):1205-1214. https://doi.org/10.1080/1744666X.2020.1672537. Epub 2019 Oct 1. PMID: 31575297
Väkevä L, Niemelä S, Lauha M, Pasternack R, Hannuksela-Svahn A, Hjerppe A, Joensuu A, Soronen M, Ylianttila L, Pastila R, Kautiainen H, Snellman E, Grönroos M, Karppinen T Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study. Photodermatol Photoimmunol Photomed. 2019 Sep;35(5):332-338. https://doi.org/10.1111/phpp.12479. Epub 2019 May 20. PMID: 31063610.
Terzić Z, Mikić M, Ljaljević A, Bojić MĐ, Bojić M. The long-term efficacy of heliotherapy in ameliorating disease severity and improving the quality of life in patients with atopic dermatitis. Postepy Dermatol Alergol. 2023 Feb;40(1):159-164. https://doi.org/10.5114/ada.2022.124681. Epub 2023 Feb 27. PMID: 36909908; PMCID: PMC9993203.
Karppinen T, Laine JP, Kautiainen H, Pasternack R, Reunala T, Snellman E. Empowering Heliotherapy in Psoriasis and Atopic Dermatitis: An Observational Study of 186 Subjects. Acta Derm Venereol. 2017 Feb 8;97(2):255-257. https://doi.org/10.2340/00015555-2506. PMID: 27383823.
Ortiz-Salvador JM, Pérez-Ferriols A. Phototherapy in Atopic Dermatitis. Adv Exp Med Biol. 2017;996:279-286. https://doi.org/10.1007/978-3-319-56017-5_23. PMID: 29124708.
Ordóñez Rubiano MF, Arenas CM, Chalela JG. UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country. Int J Dermatol. 2018 Jul;57(7):799-803. https://doi.org/10.1111/ijd.14011. Epub 2018 Apr 26. PMID: 29700815.
Pacifico A, Iacovelli P, Damiani G, Ferraro C, Cazzaniga S, Conic RRZ, Leone G, Morrone A. 'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis. J Eur Acad Dermatol Venereol. 2019 Apr;33(4):718-724. https://doi.org/10.1111/jdv.15362. Epub 2018 Dec 28. PMID: 30468530; PMCID: PMC6440836.
Rutter KJ, Farrar MD, Marjanovic EJ, Rhodes LE. Clinicophotobiological Characterization of Photoaggravated Atopic Dermatitis. JAMA Dermatol. 2022 Sep 1;158(9):1022-1030. https://doi.org/10.1001/jamadermatol.2022.2823. PMID: 35895040; PMCID: PMC9330275.
Sample A, He YY. Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed. 2018 Jan;34(1):13-24. https://doi.org/10.1111/phpp.12329. Epub 2017 Aug 2. PMID: 28703311; PMCID: PMC5760354.
Sherin PS, Vyšniauskas A, López-Duarte I, Ogilby PR, Kuimova MK. Visualising UV-A light-induced damage to plasma membranes of eye lens. J Photochem Photobiol B. 2021 Dec;225:112346. https://doi.org/10.1016/j.jphotobiol.2021.112346. Epub 2021 Oct 23. PMID: 34736070.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Mańkowska, Monika Truchta, Agata Kolano, Wiktoria Jabłońska, Marta Wardęszkiewicz, Amelia Kasprzak, Szymon Markowiak, Maciej Świercz, Anna Pejas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 363
Number of citations: 0